Apellis Pharmaceuticals, Inc. (APLS)
USD 18.37
(1.13%)
USD 18.37
(1.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 396.59 Million | 75.42 Million | 66.56 Million | 250.64 Million | - | - |
| Cost of Revenue | 58.51 Million | 5.63 Million | 5.2 Million | 25.05 Million | 288.01 Million | 127.92 Million |
| Gross Profit | 338.08 Million | 69.78 Million | 61.36 Million | 225.59 Million | -288.01 Million | -127.92 Million |
| Operating Expenses | 855.2 Million | 664.39 Million | 597.64 Million | 439.32 Million | 288.01 Million | 127.92 Million |
| Selling, General and Administrative Expenses | 500.81 Million | 277.16 Million | 176.77 Million | 139.4 Million | 67.04 Million | 22.63 Million |
| Research and Development Expenses | 354.38 Million | 387.23 Million | 420.86 Million | 299.92 Million | 220.96 Million | 105.28 Million |
| Other Expenses | - | -288 Thousand | 1.36 Million | -501 Thousand | -175.31 Thousand | -110.75 Thousand |
| Cost and Expenses | 913.71 Million | 670.03 Million | 602.84 Million | 464.37 Million | 288.01 Million | 127.92 Million |
| Operating Income | -517.12 Million | -594.61 Million | -536.27 Million | -213.72 Million | -288.01 Million | -127.92 Million |
| Interest Expense | 29.58 Million | 32.62 Million | 13.24 Million | 29.93 Million | 5.28 Million | 2.51 Million |
| Income Tax Expense | 2.13 Million | 669 Thousand | 352 Thousand | 1.84 Million | 5.1 Million | -533.32 Thousand |
| Earnings before Tax | -526.49 Million | -651.5 Million | -746 Million | -343.02 Million | -304.7 Million | -127.5 Million |
| Net Income | -528.62 Million | -652.17 Million | -746.35 Million | -344.87 Million | -309.81 Million | -127.5 Million |
| Earnings Per Share Basic | -4.45 | -6.15 | -8.84 | -4.59 | -4.98 | -2.34 |
| Earnings Per Share Diluted | -4.45 | -6.15 | -8.84 | -4.59 | -4.98 | -2.34 |
| Weighted Average Shares Outstanding | 118.67 Million | 106.11 Million | 84.42 Million | 75.16 Million | 62.22 Million | 54.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.67 Million | 106.11 Million | 84.42 Million | 75.16 Million | 62.22 Million | 54.39 Million |
| Gross Margin | 0.85 | 0.93 | 0.92 | 0.90 | - | - |
| EBIT Margin | -1.25 | -7.75 | -8.01 | -0.84 | - | - |
| Profit Margin | -1.33 | -8.65 | -11.21 | -1.38 | - | - |
| EBITDA | -495.21 Million | -617.39 Million | -731.26 Million | -312.23 Million | -298.82 Million | - |
| Earnings Before Tax Margin | -1.30 | -7.88 | -8.06 | -0.85 | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 176.57 Million | 199.68 Million | 172.32 Million | 396.59 Million | 146.37 Million | 99.18 Million |
| Cost of Revenue | 33.55 Million | 23.54 Million | 20.65 Million | 60.21 Million | 19.91 Million | 22.41 Million |
| Gross Profit | 143.01 Million | 176.13 Million | 151.67 Million | 336.37 Million | 126.46 Million | 76.77 Million |
| Operating Expenses | 210.55 Million | 205.57 Million | 213.76 Million | 853.49 Million | 210.98 Million | 225.06 Million |
| Selling, General and Administrative Expenses | 121.98 Million | 127.63 Million | 129.06 Million | - | 141.7 Million | 145.64 Million |
| Research and Development Expenses | 88.56 Million | 77.94 Million | 84.7 Million | - | 69.28 Million | 79.42 Million |
| Other Expenses | - | 24 Thousand | -499 Thousand | -727 Thousand | 219 Thousand | -603 Thousand |
| Cost and Expenses | 244.11 Million | 229.12 Million | 234.41 Million | 913.71 Million | 230.89 Million | 247.47 Million |
| Operating Income | -67.53 Million | -29.44 Million | -62.09 Million | -517.12 Million | -84.51 Million | -148.29 Million |
| Interest Expense | -12.53 Million | 9.35 Million | 6.96 Million | 29.58 Million | 7.4 Million | -7.31 Million |
| Income Tax Expense | 592 Thousand | 114 Thousand | 170 Thousand | 2.13 Million | 1.42 Million | 233 Thousand |
| Earnings before Tax | -56.85 Million | -37.54 Million | -66.25 Million | -526.49 Million | -87.15 Million | -140 Million |
| Net Income | -57.44 Million | -37.65 Million | -66.42 Million | -528.62 Million | -88.57 Million | -140.23 Million |
| Earnings Per Share Basic | -0.46 | -0.30 | -0.54 | - | -0.73 | -1.17 |
| Earnings Per Share Diluted | -0.46 | -0.30 | -0.54 | - | -0.73 | -1.17 |
| Weighted Average Shares Outstanding | 123.9 Million | 123.9 Million | 122.95 Million | 118.67 Million | 121.23 Million | 120.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.9 Million | 123.9 Million | 122.95 Million | 118.67 Million | 121.23 Million | 120.29 Million |
| Gross Margin | 0.81 | 0.88 | 0.88 | 0.85 | 0.86 | 0.77 |
| EBIT Margin | -0.38 | -0.15 | -0.36 | - | -0.57 | -1.50 |
| Profit Margin | -0.33 | -0.19 | -0.39 | -1.33 | -0.61 | -1.41 |
| EBITDA | -67.53 Million | -28.99 Million | -61.64 Million | - | -84.02 Million | -148.29 Million |
| Earnings Before Tax Margin | -0.38 | -0.15 | -0.36 | -1.30 | -0.58 | -1.50 |
ABO
4634
SNM
VTWRF
QD
9213